XIMONTH LUNG ENHANCEMENT AND CARE INHALER- glycerin liquid

XIMONTH Lung Enhancement And Care Inhaler by

Drug Labeling and Warnings

XIMONTH Lung Enhancement And Care Inhaler by is a Otc medication manufactured, distributed, or labeled by Guangdong Ouhoe Biotechnology Co., Ltd.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENTS

TARAXACUM OFFICINALE,TURMERIC,ARTEMISIA VULGARIS ROOT,SAFFLOWER

PURPOSE

Promotes detoxification and purifies the body; soothes nasal cavity and relieves discomfort; relaxes lungs and supports breathing

USE

1.Open the lid.

2. Place this product ndeors.

3. Inhale slowly for 5 seconds and then exhale slowly for relief.

WARNINGS

Please keep out of reach of children. Do not swallow.Please clean your hands before use to ensure the best results from the product. Discontinue use if signs of irritation or rash occur. Store in a cool and dry place.

DO NOT USE

Discontinue use if signs of irritation or rash occur.

STOP USE

Discontinue use if signs of irritation or rash occur.

KEEP OUT OF REACH OF CHILDREN

Please keep out of reach of children. Do not swallow.

STORAGE AND HANDLING

Store in a cool and dry place.

INACTIVE INGREDIENT

GLYCERIN

INDICATIONS & USAGE

DOSAGE & ADMINISTRATION

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

XIMONTH LUNG ENHANCEMENT AND CARE INHALER 
glycerin liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 84744-054
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
TURMERIC (UNII: 856YO1Z64F) (TURMERIC - UNII:856YO1Z64F)	TURMERIC	0.18 mg  in 1.8 mg
TARAXACUM OFFICINALE (UNII: 39981FM375) (TARAXACUM OFFICINALE - UNII:39981FM375)	TARAXACUM OFFICINALE	0.54 mg  in 1.8 mg
ARTEMISIA VULGARIS ROOT (UNII: 32MP823R8S) (ARTEMISIA VULGARIS ROOT - UNII:32MP823R8S)	ARTEMISIA VULGARIS ROOT	0.27 mg  in 1.8 mg
SAFFLOWER (UNII: 4VBL71TY4Y) (SAFFLOWER - UNII:4VBL71TY4Y)	SAFFLOWER	1.27 mg  in 1.8 mg

Inactive Ingredients
Ingredient Name	Strength
GLYCERIN (UNII: PDC6A3C0OX)	0.54 mg  in 1.8 mg

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 84744-054-01	1.8 mg in 1 BOX; Type 0: Not a Combination Product	10/22/2024

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M014	10/22/2024

Labeler - Guangdong Ouhoe Biotechnology Co., Ltd. (843651433)

Registrant - Guangdong Ouhoe Biotechnology Co., Ltd. (843651433)

Establishment
Name	Address	ID/FEI	Business Operations
Guangdong Ouhoe Biotechnology Co., Ltd.		843651433	manufacture(84744-054)